A Study of LY3415244 in Participants With Advanced Solid Tumors

J1C-MC-JZDA -

The goal of this study is to evaluate the safety of LY3415244 administered as monotherapy to participants with advanced solid tumors.

Trial Summary

Age Range
≥18 years
Conditions the trial is for
What the trial is testing?
Could I receive a Placebo?
No
Enrollment Goal
12
Trial Dates
Nov 22, 2018 - Oct 9, 2019
How long will I be in the trial?
Participation in this trial will last at least 8 weeks and possibly longer if your disease does not progress.
Trial Phase
I

Lilly Trial Alerts

Not the right fit? Sign up to receive updates about new trials that are listed or when a new trial site begins enrolling near you.